Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 958334-24-2 | MDL No. : | MFCD11518964 |
Formula : | C10H7BrN2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HSKHAOKCHBJDBO-UHFFFAOYSA-N |
M.W : | 267.08 | Pubchem ID : | 45790081 |
Synonyms : |
|
Num. heavy atoms : | 15 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.1 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 58.52 |
TPSA : | 52.08 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.69 cm/s |
Log Po/w (iLOGP) : | 2.25 |
Log Po/w (XLOGP3) : | 1.75 |
Log Po/w (WLOGP) : | 2.18 |
Log Po/w (MLOGP) : | 1.46 |
Log Po/w (SILICOS-IT) : | 2.44 |
Consensus Log Po/w : | 2.01 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.96 |
Solubility : | 0.293 mg/ml ; 0.0011 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.46 |
Solubility : | 0.924 mg/ml ; 0.00346 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.26 |
Solubility : | 0.0147 mg/ml ; 0.0000552 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 1.81 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With sodium hydroxide; In ethanol; water; at 60.0℃; for 5.0h; | Methyl 7-bromo-1,5-naphthyridine-3-carboxylate (26 g, 98 mmol) was dissolved in ethanol (150 mL)Add 10% NaOH aqueous solution (260 mL), add the reaction solution to 60 C for 5 h, and evaporate to remove ethanol.Adjust the pH to 4-6 with 2M hydrochloric acid, precipitate a solid, and filter with suction.Drying gave the desired product 7-bromo-1,5-naphthyridin-3-carboxylic acid (25 g, white solid, yield 99%). |
Example 667-BROMO-[1,5]NAPHTHYRIDINE-3-CARBOXYLIC ACID [(R)-1-(2-FLUORO-4-METHANE-SULFONYLAMINO-5-METHYL-PHENYL)-ETHYL]-AMIDE 66A) To a solution of <strong>[958334-24-2]methyl 7-bromo-1,5-naphthyridine-3-carboxylate</strong> (200 mg; 0.70 mmol) in Methanol (3 mL, 70 mmol), 1N Sodium hydroxide in water (3 mL, 3 mmol) was added and the reaction was stirred at room temperature 2 h. The reaction mixture was neutralized with 1N HCl, dried (MgSO4), filtered and evaporated. The crude residue was used in the next step without further purification. m/z=255.11 (M+1), r.t. 2.56 min. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With N-Bromosuccinimide; acetic acid; at 100.0℃; for 6.0h; | Methyl 1,5-naphthyridin-3carboxylate (17.5 g, 93.0 mmol), acetic acid (150 mL) was mixed and heated to 100 C,N-bromosuccinimide (17.4 g, 97.7 mmol) was added portionwise, and the reaction was carried out at 100 C for 6 h.The reaction was monitored by TLC.Spin dry, add 1 water (100 mL), stir, filter, filter cake wash, EA wash,Drying gave 7-bromo-1,5-naphthyridin-3-carboxylic acid methyl ester (22.5 g, white solid, yield 92%). |
[ 958334-48-0 ]
Ethyl 7-bromo-1,5-naphthyridine-3-carboxylate
Similarity: 0.97
[ 1190312-64-1 ]
Methyl 3-bromo-1H-pyrrolo[3,2-b]pyridine-6-carboxylate
Similarity: 0.95
[ 1638759-73-5 ]
Methyl 6-bromo-1H-pyrrolo[3,2-b]pyridine-3-carboxylate
Similarity: 0.95
[ 1615714-30-1 ]
Ethyl 6-bromo-1H-pyrrolo[3,2-b]pyridine-3-carboxylate
Similarity: 0.92
[ 1956378-91-8 ]
Ethyl 3-bromo-1H-pyrrolo[3,2-b]pyridine-6-carboxylate
Similarity: 0.92
[ 958334-48-0 ]
Ethyl 7-bromo-1,5-naphthyridine-3-carboxylate
Similarity: 0.97
[ 1190312-64-1 ]
Methyl 3-bromo-1H-pyrrolo[3,2-b]pyridine-6-carboxylate
Similarity: 0.95
[ 1638759-73-5 ]
Methyl 6-bromo-1H-pyrrolo[3,2-b]pyridine-3-carboxylate
Similarity: 0.95
[ 1615714-30-1 ]
Ethyl 6-bromo-1H-pyrrolo[3,2-b]pyridine-3-carboxylate
Similarity: 0.92
[ 1956378-91-8 ]
Ethyl 3-bromo-1H-pyrrolo[3,2-b]pyridine-6-carboxylate
Similarity: 0.92
[ 958334-48-0 ]
Ethyl 7-bromo-1,5-naphthyridine-3-carboxylate
Similarity: 0.97
[ 958332-87-1 ]
7-Bromo-1,5-naphthyridine-3-carboxylic acid
Similarity: 0.92
[ 1257852-54-2 ]
Ethyl 4,7-dibromo-1,5-naphthyridine-3-carboxylate
Similarity: 0.88
[ 1261365-76-7 ]
Methyl 1,5-naphthyridine-3-carboxylate
Similarity: 0.83
[ 1447608-02-7 ]
Ethyl 1,5-naphthyridine-3-carboxylate
Similarity: 0.80